Recent News

• 08.05.2026 - Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
• 08.03.2026 - Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
• 08.02.2026 - Comment on image-sub-4445 by Digital Profit
• 07.29.2026 - Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
• 05.19.2026 - Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
• 05.14.2026 - Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
• 05.12.2026 - Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
• 05.12.2026 - Top Rapid Cashout Gambling Platforms in Australia
• 05.08.2026 - Чемпіон казино — якісна площадка з метою гральних розваг в українському ринку
• 05.08.2026 - Tugabet Casino – Platforma de jocuri personală Premium de jocuri de Gaming de Noroc Online

Recent Filings

• 08.05.2026 - 8-K Current report
• 08.05.2026 - EX-99.1 EX-99.1
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 8-K Current report
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities